Article

A single amino acid residue change in the P protein of parainfluenza virus 5 elevates viral gene expression.

Center of Molecular Immunology and Infectious Disease, Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA 16802, USA.
Journal of Virology (Impact Factor: 4.65). 08/2008; 82(18):9123-33. DOI: 10.1128/JVI.00289-08
Source: PubMed

ABSTRACT Parainfluenza virus 5 (PIV5) is a prototypical paramyxovirus. The V/P gene of PIV5 encodes two mRNA species through a process of pseudotemplated insertion of two G residues at a specific site during transcription, resulting in two viral proteins, V and P, whose N termini of 164 amino acid residues are identical. Previously it was reported that mutating six amino acid residues within this identical region results in a recombinant PIV5 (rPIV5-CPI-) that exhibits elevated viral protein expression and induces production of cytokines, such as beta interferon and interleukin 6. Because the six mutations correspond to the shared region of the V protein and the P protein, it is not clear whether the phenotypes associated with rPIV5-CPI- are due to mutations in the P protein and/or mutations in the V protein. To address this question, we used a minigenome system and recombinant viruses to study the effects of mutations on the functions of the P and V proteins. We found that the P protein with six amino acid residue changes (Pcpi-) was more efficient than wild-type P in facilitating replication of viral RNA, while the V protein with six amino acid residue changes (Vcpi-) still inhibits minigenome replication as does the wild-type V protein. These results indicate that elevated viral gene expression in rPIV5-CPI- virus-infected cells can be attributed to a P protein with an increased ability to facilitate viral RNA synthesis. Furthermore, we found that a single amino acid residue change at position 157 of the P protein from Ser (the residue in the wild-type P protein) to Phe (the residue in Pcpi-) is sufficient for elevated viral gene expression. Using mass spectrometry and (33)P labeling, we found that residue S157 of the P protein is phosphorylated. Based on these results, we propose that phosphorylation of the P protein at residue 157 plays an important role in regulating viral RNA replication.

0 Bookmarks
 · 
106 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mumps virus (MuV), a paramyxovirus containing a negative sense non-segmented RNA genome, is a human pathogen that causes an acute infection with symptoms ranging from parotitis to mild meningitis and severe encephalitis. Vaccination against mumps virus has been effective in reducing mumps cases. However, recently large outbreaks have occurred in vaccinated populations. There is no anti-MuV drug. Understanding replication of MuV may lead to novel anti-viral strategies. MuV RNA-dependent RNA polymerase minimally consists of the phosphoprotein (P) and the large protein (L). The P protein is heavily phosphorylated. To investigate the roles of serine (S) and threonine (T) residues of P in viral RNA transcription and replication, P was subjected to mass spectrometry and mutational analysis. P, a 392-amino acid residue protein, has 64 S and T residues. We have found that mutating nine S/T residues significantly reduced, and mutating residue T at 101 to A (T101A) significantly enhanced, activity in a minigenome system. A recombinant virus containing the P-T101A mutation (rMuV-P-T101A) was recovered and analyzed. rMuV-P-T101A grew to higher titers and had increased protein expression at early time points. Together, these results suggest that phosphorylation of MuV-P-T101 plays a negative role in viral RNA synthesis. This is the first time that the P protein of a paramyxovirus has been systematically analyzed for S/T residues that are critical for viral RNA synthesis.IMPORTANCE Mumps virus (MuV) is a re-emerging paramyxovirus that caused large outbreaks in the U.S. where vaccination coverage is very high. There is no anti-MuV drug. In this work, we have systematically analyzed roles of Ser/Thr residues of MuV P in viral RNA synthesis. We have identified S/T residues of P critical for MuV RNA synthesis and phosphorylation sites that are important for viral RNA synthesis. The work leads to a better understanding of viral RNA synthesis as well as to potential novel strategies to control mumps.
    Journal of Virology 02/2014; · 4.65 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Untreated rabies virus (RABV) infection leads to death. Vaccine and post-exposure treatment have been effective in preventing RABV infection. However, due to cost, rabies vaccination and treatment have not been wildely used in developing countries. There are 55,000 human death caused by rabies annually. An efficacious and cost effective rabies vaccine is needed. Parainfluenza virus 5 (PIV5) is thought to contribute to kennel cough and kennel cough vaccines containing live PIV5 have been used in dogs for many years. In this work a PIV5-vectored rabies vaccine has been tested in mice. A recombinaint PIV5 encoding RABV glycoprotein (G) (rPIV5-RV-G) was administrated to mice via intranasal (IN), intramuscular (IM) and oral inoculation. The vaccinated mice were challenged with 50 lethal intracerebral rabies challenge dose (LD(50)) of CVS-24. A single dose of 10(6) PFU of rPIV5-RV-G was sufficient for 100% protection when administrated via IN route. The mice vaccinated with a single dose of 10(8) PFU of rPIV5-RV-G via IM route provided very robust protection (90%-100%). Intriguingly, the mice vaccinated orally with a single dose of 10(8) PFU of rPIV5-RV-G showed 50% survival rate, which is comparable to the 60% survival rate of an attenuated rabies vaccine strain rLBNSE-inoculated mice. This is first report of an orally effective rabies vaccine candidate in animals based on PIV5 as a vector. These results indicate the rPIV5-RV-G is an excellent candidate for a new generation of recombinant rabies vaccine for humans and animals and PIV5 is a potential vector for oral vaccines.
    Journal of Virology 12/2012; · 4.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In order to define poliovirus (PV) neurovirulence at the molecular level, we comparatively analyze the primary amino acid sequence of Mahoney, a neurovirulent PV strain, versus (i) Sabin, an attenuated PV strain, and (ii) IS1, a PV isolate obtained in temporal association to a paralysis event from a polio vaccinated subject. We identify and describe 12 pentapeptides that, originally present in the Mahoney sequence, are changed in the non-neurovirulent Sabin strain, and, successively, restored in IS1 strain.
    Journal of Basic Microbiology 05/2013; · 1.20 Impact Factor

Full-text (2 Sources)

Download
24 Downloads
Available from
Jun 6, 2014